BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Wang X, Wang B, Chi W, Li Z, Zhang M, Shen Y, Liu X, Lu Y, Liu Y. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang R, Zhang H, Shi H, Zhang D, Zhang Z, Liu H. Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges. Drug Deliv 2022;29:3052-70. [PMID: 36146939 DOI: 10.1080/10717544.2022.2125601] [Reference Citation Analysis]
2 Chen HW, Zhou JW, Zhang GZ, Luo ZB, Li L, Kang XW. Emerging role and therapeutic implication of mTOR signalling in intervertebral disc degeneration. Cell Prolif 2023;56:e13338. [PMID: 36193577 DOI: 10.1111/cpr.13338] [Reference Citation Analysis]
3 Peng Y, Wang L, Zhang Z, He X, Fan Q, Cheng X, Qiao Y, Huang H, Lai S, Wan Q, He M, He H. Puerarin activates adaptive autophagy and protects the myocardium against doxorubicin-induced cardiotoxicity via the 14–3-3γ/PKCε pathway. Biomedicine & Pharmacotherapy 2022;153:113403. [DOI: 10.1016/j.biopha.2022.113403] [Reference Citation Analysis]
4 Pan D, Tang Z, Zhang Z, Li QX. Action Mechanisms and Pharmacokinetics of Dihydromyricetin against Obesity. ACS Food Sci Technol . [DOI: 10.1021/acsfoodscitech.2c00145] [Reference Citation Analysis]
5 Chen Y, Hamidu S, Yang X, Yan Y, Wang Q, Li L, Oduro PK, Li Y. Dietary Supplements and Natural Products: An Update on Their Clinical Effectiveness and Molecular Mechanisms of Action During Accelerated Biological Aging. Front Genet 2022;13:880421. [PMID: 35571015 DOI: 10.3389/fgene.2022.880421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]